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ABSTRACT:  
Purpose: A genetic correlation is the proportion of phenotypic variance between traits that is 
shared on a genetic basis. Here we explore genetic correlations between diabetes- and 
glaucoma-related traits.  
Design: Cross-sectional study. 
 
Methods: We assembled genome-wide association study summary statistics from European-
derived participants regarding diabetes-related traits like fasting blood sugar (FBS) and type 2 
diabetes (T2D) and glaucoma-related traits (intraocular pressure (IOP), central corneal thickness 
(CCT), corneal hysteresis (CH), corneal resistance factor (CRF), cup-disc ratio (CDR), and 
primary open-angle  glaucoma (POAG)). We included data from the National Eye Institute 
Glaucoma Human Genetics Collaboration Heritable Overall Operational Database, the UK 
Biobank and the International Glaucoma Genetics Consortium.  We calculated genetic 
correlation (rg) between traits using linkage disequilibrium score regression. We also calculated 
genetic correlations between IOP, CCT and selected diabetes-related traits based on individual 
level phenotype data in two Northern European population-based samples using pedigree 
information and Sequential Oligogenic Linkage Analysis Routines (SOLAR).   
   
Results: Overall, there was little rg between diabetes- and glaucoma-related traits. Specifically, 
we found a non-significant negative correlation between T2D and POAG (rg=-0.14; p=0.16). 
Using SOLAR, the genetic correlations between measured IOP, CCT, FBS, fasting insulin and 
hemoglobin A1c, were null.  In contrast, genetic correlations between IOP and POAG (rg ≥0.45; 
p≤3.0E-04) and between CDR and POAG were high (rg =0.57; p=2.8E-10). However, genetic 
correlations between corneal properties (CCT, CRF and CH) and POAG were low (rg range: -
0.18 – 0.11) and non-significant (p≥0.07).   
 
Conclusion:  These analyses suggest there is limited genetic correlation between diabetes- and 
glaucoma-related traits.   
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Introduction: 
 Clarifying the relationship between diabetes mellitus and primary open-angle glaucoma 
(POAG) could help prioritize glaucoma detection efforts and focus glaucoma drug discovery. 
Studies show that patients with diabetes have higher intraocular pressure (IOP) than patients 
without diabetes and that increased fasting blood sugar (FBS) is associated with higher IOP.1-6 
However, the link between diabetes and IOP is complex as diabetes alters corneal hysteresis 
(CH) and corneal resistance factor (CRF), possibly confounding the true correlation between 
diabetes and IOP.7, 8 The Ocular Response Analyzer (ORA) noncontact tonometer (NCT) 
generates both a Goldmann-correlated IOP (IOPg) and a cornea-compensated IOP (IOPcc), with 
the latter adjusting for corneal biomechanical properties. Among 110,573 participants in the UK 
Biobank where IOP was measured with the ORA NCT, self-reported diabetes was associated 
with higher IOPg but there was no significant difference in IOPcc between subjects with and 
without diabetes in multivariate analysis.9 A meta-analysis of seven prospective cohort studies 
also shows that type 2 diabetes (T2D) is associated with increased risk of POAG;10 however, this 
meta-analysis is not consistent with a study finding that POAG patients with T2D and no 
diabetic retinopathy had significantly slower rates of retinal nerve fiber layer thinning compared 
to POAG patients without T2D.11  
 Several other correlations between diabetes-related traits and IOP are notable. For 
example, there was a positive association between postprandial glucose level and IOP in patients 
with and without diabetes.12, 13 Among non-obese individuals,14 there was a positive relationship 
between insulin resistance and IOP.15 Serum diabetes-related biomarkers positively associated 
with IOP include hemoglobin A1c (HbA1c),16 high-density lipoprotein (HDL) and triglyceride 
(TG).2 Several studies also showed a positive correlation between body mass index (BMI), a 
continuous trait positively linked to T2D,17-19 and IOP.4, 20 Currently, it is unclear if any of these 
diabetes-related traits translate into increased vulnerability to POAG. 
 Genetic analyses offer powerful tools to analyze relationships between various traits 
without confounding by reverse causality, measurement artifact or detection bias. One such tool 
is linkage disequilibrium (LD) score regression, which estimates the genetic correlation (rg) 
between traits using genome-wide association study (GWAS) summary statistics.21, 22 For 
example, Pickrell et al. reported strong genetic correlations between each of the following 
continuous diabetes-related traits and T2D using LD score regression: fasting blood sugar (FBS), 
TG, low-density lipoprotein (LDL), HDL and BMI.23 For glaucoma-related traits, a strong 
genetic correlation between IOP measured with Goldmann applanation tonometry and POAG 
was reported using GWAS summary data from two large European-derived consortia.24 Using 
LD score regression in a Japanese population, Shiga et al25 found a positive genetic correlation 
between T2D and POAG (rg=0.27; p=2.00E-04) but Kinai et al. found no significant correlations 
between various quantitative diabetes traits and POAG in the same population.26 Another 
approach is to form panels of genome-wide significant markers for a trait and test them in 
relation to another trait of interest. In a multiethnic US population (n=69,685), 39 genome-wide 
significant diabetes alleles were not collectively associated with POAG (n=3,554 cases) after 
adjustment for T2D.27   
A repository of existing GWAS summary statistics and an atlas of genetic cross-
correlations can be found at LD Hub.28 Given the preponderance of epidemiological evidence 
linking diabetes and glaucoma, we tested the hypothesis that there would be genetic correlations 
between diabetes- and glaucoma related traits. First, we used LD score regression to explore the 
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relations between quantitative glaucoma-related traits (IOP measured using various techniques in 
the International Glaucoma Genetics Consortium, as well as corneal-compensated IOP (IOPcc) 
and Goldmann-correlated IOP (IOPg) − both measured with the ORA in the UK BioBank study, 
central corneal thickness (CCT), CH, CRF, cup-disc ratio (CDR) and POAG) using existing 
GWAS summary statistics. Next, we performed LD score regression to assess the genetic 
correlation between diabetes-related traits (2-hour glucose, FBS, HbA1c, fasting insulin (FI), 
BMI, TG, LDL, HDL and T2D) and glaucoma-related traits. Finally, we compared our estimates 
of genetic correlations between selected diabetes quantitative traits and glaucoma quantitative 
traits to values derived from directly measured traits leveraging pedigree information in two 
Northern European island cohorts.  
 
Methods: 
The Institutional Review Board (IRB) of Partners Healthcare prospectively approved the 
genetic correlation analyses described in this work. The Icahn School of Medicine IRB has a 
reliance agreement with Partners to conduct this research. These analyses represent a 
retrospective study of publicly available summary genotype data. The island cohort studies 
described below were approved by the Scotland National Health Study.  
Assembly of Genome-Wide Association Study Summary Statistics 
We assembled publicly available GWAS summary statistics and outlined the traits, 
sample sizes, population characteristics, and trait heritability based on GWAS data for relevant 
studies in Table 1.29-38 The GWAS summary data were accessed at 
http://jass.pasteur.fr/selectPhenotypes.html and at http://ldsc.broadinstitute.org. We used the 
European-derived subgroups of these studies. Details such as study demographics, detailed 
phenotype collection methods, adjustments for covariates, the genotyping platforms used and 
number of single nucleotide polymorphisms (SNPs) that passed quality control can be found in 
references listed in Table 1. The trait heritability based on classic twin studies and family studies 
as well as the methodology for determining these traits can also be found by referring to the 
appropriate references in Table 1. Heritability based on classic twin and family studies was high 
overall and upward of 0.95 for CCT39 (Table 1). As expected, calculations of heritability for all 
these traits based on summary GWAS data were lower than values estimated from classic twin 
studies. Several hypotheses for the source of this ‘missing heritability’ have been proposed in the 
genetics literature.40  In the studies of quantitative diabetes traits, efforts were taken to exclude 
patients with known diabetes. The studies of blood lipids and BMI contains patients with and 
without dyslipidemia – there was no concerted effort to exclude patients with diabetes.  In the 
studies of IOP measured in various ways, studies of CDR and in the studies of corneal 
biophysical properties, less than 1.5% of subjects were on treatment for glaucoma.  
 
 
Genetic correlation between traits analyses 
 The methodology for estimating genetic correlation between traits using high throughput 
allelic markers has been previously described21 and appears in the Appendix. We provide an 
overview of the method here.  The genetic correlation ,  measures of the covariance between 
the genetic components of two traits scaled by their respective heritability.  It ranges between -1 
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and +1, although occasional out-of-bounds-estimates arise due to estimation error.41, 42 Negative 
rg between trait pairs mean that alleles that are positively associated with phenotype 1 are 
negatively associated phenotype 2. Positive rg between trait pairs mean that there are common 
alleles positively associated between both traits. An absolute value of rg ≥0.5 can be considered 
as strong while an absolute rg ≤0.12 can be regarded as weak. P-values < 6.9E-04 associated with 
 were considered as significant to correct for the multiple comparisons made (9 diabetes traits x 
8 glaucoma traits). Power calculations41 for all possible bivariate analyses are provided in 
Supplemental Table 1. 
 
  
The Orkney and Shetlandic Cohorts: Pedigrees with measured intraocular pressure, central 
corneal thickness and serum diabetes-related biomarkers.   
The Orkney Complex Disease Study (ORCADES) is a family-based, cross-sectional 
study that seeks to identify genetic factors influencing cardiovascular and other disease risk in 
the isolated archipelago of the Orkney Isles in northern Scotland.43 In total, 2078 
participants aged 16-100 years were recruited between 2005 and 2011, most having three or four 
grandparents from Orkney, the remainder with two Orcadian grandparents.  
The Viking Health Study (VIKING) is a family-based, cross-sectional study that aims to 
identify genetic factors influencing cardiovascular and other disease risk in the population isolate 
of the Shetland Islands in northern Scotland. In total, 2105 participants were recruited between 
2013 and 2015, each having at least three grandparents from Shetland. 
Genetic diversity in both the ORCADES and VIKING populations is less than mainland 
Scotland, consistent with high levels of endogamy historically.44 In both cohorts, fasting blood 
samples were collected and many health-related phenotypes, including IOP and CCT as well as 
environmental exposures were measured. Specifically, serum glucose, fasting insulin and HbA1c 
were measured.  CCT was measured using an ultrasound pachymeter (Heidelberg Engineering; 
Heidelberg, Germany). IOP was measured with a tonopen (Reichert Technologies; Buffalo, NY). 
 
Genetic correlations in the Orkney and Shetlandic Cohorts 
We used SOLAR (Sequential Oligogenic Linkage Analysis Routines) to decompose 
phenotypic covariances for IOP, CCT and diabetes-related serum biomarkers from our island 
cohorts into environmental, phenotypic and genetic components using pedigree data. We used 
measures averaged between both eyes of a participant. We excluded measures from eyes with a 
history of surgery that might affect CCT or IOP measurements and from participants with 
keratoconus. HbA1c values from individuals with diabetes or FBS >7mmol/l were also excluded. 
IOPs were not adjusted for CCT or transformed but were adjusted for age and sex. CCT, adjusted 
for age and sex, underwent z-score transformation while FBS, HbA1c and FI underwent rank 
transformation, with FI undergoing natural log transformation first. All serum diabetes 
biomarkers were further adjusted for sex, age, age2 and BMI. P-values < 0.0042 were considered 
significant to correct for the multiple comparisons made (2 glaucoma traits × 3 diabetes traits x 2 
cohorts).   
 
Results: 
 Genetic correlation between the various glaucoma-related quantitative traits and POAG 
revealed significant trends (Table 2). There was a positive genetic association between IOP 
measured in the IGGC and POAG as previously reported (rg = 0.45; Standard Error (SE) = 0.12; 
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p = 3.0E-04).24 Similarly there were strong positive genetic correlations between IOPcc and 
POAG (rg = 0.50; SE = 0.09; p = 5.5E-08) and between IOPg and POAG (rg = 0.60; SE = 0.15; p 
= 4.3E-05). None of the corneal features (CCT, CH or CRF) showed significant genetic 
correlation with CDR (p≥0.13) or POAG (p≥0.07). Interestingly, while CCT showed strong 
positive genetic correlations with IOPg (rg=0.58; SE=0.07; p=1.8E-15) and IOPg (rg = 0.48; SE = 
0.07; p=3.7E-12), it did not show significant genetic correlation with IOPcc (rg = 0.07; SE = 
0.05; p=0.21). Furthermore, there was also a strong positive genetic correlation between CDR 
and POAG (rg = 0.57; SE = 0.09; p = 2.8E-10). IOPcc showed a positive genetic correlation with 
CDR (rg = 0.16; SE = 0.05; p = 9.3E-04) that was not significant after correcting for multiple 
comparisons. We found strong genetic correlations between IOP measured in various ways in the 
IGGC as well as between IOPg with the following corneal biophysical traits: CCT, CH and CRF 
(range of rg = 0.31 - 0.81; p≤3.2E-07).   
 Next, we examined the genetic correlations between BMI, blood lipid traits and 
glaucoma-related traits (Table 3) as well as the genetic correlations between diabetes- and 
glaucoma-related traits (Table 4). Overall, these results were null after correction for multiple 
comparisons. Notably, there were non-significant inverse genetic correlations between HbA1c 
and POAG (rg = -0.31; SE = 0.14; p = 0.02) and between T2D and POAG (rg = -0.14; SE = 0.10; 
p = 0.16).  
  The ORCADES and VIKING cohorts offered an opportunity to assess the phenotypic 
correlations between measured glaucoma-related traits and measured serum biomarkers related 
to diabetes as well as genotypic correlations based on pedigree information, as opposed to 
genetic biomarkers (Supplemental Tables 2 and 3). Consistent with classic twin studies,39 the 
heritability of CCT was high (range: 0.78-0.85). Heritability for IOP was 0.13-0.14 in 
ORCADES and 0.25 in the VIKING study. Phenotypic correlations were very low (<6%) 
between CCT or IOP and measured diabetes-related serum biomarkers. We found no statistically 
significant genetic or environmental correlations between diabetes- and glaucoma-related traits 
after correction for multiple testing in both cohorts (Supplemental Tables 2 and 3). In the 
VIKING cohort, there was a strong genetic correlation between IOP and CCT (rg = 0.45; p = 
9.7E-06). In both cohorts, a modest phenotypic correlation (rp) between IOP and CCT was 
observed (rp = 0.16; p = 7.8E-08 in ORCADES; rp = 0.26; p = 3.3E-25 in the VIKING study).   
 
Discussion 
 Using a genome-wide genetic correlation approach, we found no significant relationship 
between diabetes- and glaucoma-related traits after adjustment for multiple comparisons. These 
null results must be assessed in context of the power of this study to find significant associations. 
A consensus estimate of “good” power is based on the square root of the product of the 
heritability and sample size for the traits having a value >4500.41 The power was considered to 
be “good” or better for 47 out of 56 bivariate analyses between quantitative diabetes- and 
quantitative glaucoma-related traits (see Supplemental Table 1). There was one nominal 
positive association between IOP measured in the IGGC and FBS with subpar power (rg =0.23; 
p=0.0075; power product=3917) but more adequately powered associations between IOPg and 
FBS and IOPcc and FBS were definitely null (p≥0.47; power product ≥ 6772; see Table 4 and 
Supplemental Table 1). T2D did not show any significant genetic correlations with any of the 
seven quantitative glaucoma-related traits (p≥0.16) and for all of these bivariate analyses there 
was at least “good” power to observe such an association (power product ≥ 4800; Supplemental 
Table 3). POAG and T2D are categorical traits and the analysis for genetic correlation between 
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them was slightly underpowered (power product=3957); yet, the result was in the inverse 
direction (rg=-0.14) and not significant (p=0.16). Our findings using GWAS statistics were 
consistent with individual level data from two population pedigrees and do not support a genetic 
relationship between diabetes and glaucoma.   
 Our result showing a non-significant inverse genetic correlation between T2D and POAG 
runs contrary to the significant positive correlation between these quantitative traits in a Japanese 
population.25 The numbers of cases in the genome-wide datasets were comparable between the 
Asian and our European sample so power differences were unlikely but there could be 
differences in genetic structure between these groups that account for these differences. For 
example, LOXL1 was found to be a genome-wide marker for POAG in Japanese subjects,25 but 
to date LOXL1 markers are not associated with POAG in European-derived Caucasians.45 Using 
the same Japanese population, Kinai et al. did not find significant genetic correlations between 
diabetes quantitative traits (HDL, LDL, TG, blood sugar, and HbA1c) and glaucoma, a finding 
consistent with our results.26 Furthermore, in a US-based multiethnic population, a panel of 
genome-wide genetic biomarkers for T2D were not associated with POAG.27   
 Several diabetes quantitative traits are positively related to IOP in epidemiological 
studies;1-6 yet, we find no genetic correlations between these quantitative diabetes traits and IOP. 
Overall, while CCT is increased in patients with diabetes based on several studies,46-48 this 
corneal feature only partially mediated IOP variation in a study from Singapore.6 While CCT is a 
static biophysical parameter, CH and CRF are dynamic biomechanical properties that are also 
affected by diabetes control.49, 50 Overall, accounting for CCT, CH and CRF may not completely 
explain how the diabetic process leads to increased IOP as measured by Goldman applanation 
tonometry. Nonetheless, the large UK BioBank study suggests there is no relationship between 
self-reported diabetes and cornea-compensated IOP.9 Of course, both epidemiological51 and 
genetic correlation analysis24 strongly link IOP to POAG risk, and our study affirms the latter 
regardless of how IOP is measured. Yet the genetic correlations between any corneal phenotype 
(CCT, CRF and CH) and POAG are not significant. Furthermore, while genetic correlations 
between IOP measured in the IGGC and corneal phenotypes and between IOPg and corneal 
phenotypes are all high, there was no correlation between IOPcc and CCT. Overall these data 
suggest that from a genetic perspective CCT, CH and CRF quantify features unrelated to POAG, 
although they may be related to POAG phenotypically.  
 The epidemiological association between diabetes and glaucoma is somewhat more 
controversial but most studies indicate a positive association between the two conditions.52 Our 
genetic correlation study, which is relatively free of bias related to reverse causation or disease 
detection, indicates a non-significant inverse genetic correlation between T2D and POAG. 
Furthermore, genetic correlations between IOP and T2D and between CDR and T2D are also 
null despite adequate power (power product ≥ 4800; Supplemental Table 1). Notably, we found 
strong genetic correlations between CDR and POAG despite only modest power (power product 
= 4400; Supplemental Table 1) and modest but non-significant correlations between CDR and 
IOP, suggesting that, from a genetic perspective, T2D genetic markers are largely not shared 
with POAG in European populations. These genetic findings may not be applicable to people of 
other ancestry but do seem adequately powered to address our study question and call for more 
prospective study of the relationship between diabetes and POAG using a population that is free 
of disease at baseline and is systematically monitored for both conditions.  
 Several longitudinal studies found a modest positive association between measured BMI 
and IOP,53-55 while epidemiological studies of the relation between BMI and incident POAG had 
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mixed results.56, 57 Furthermore some studies suggest that components of the metabolic syndrome 
are associated with open-angle glaucoma58 but this association may vary by BMI status.59 BMI is 
a readily obtainable phenotype with the largest summary GWAS data set available among the 
traits we studied.33 There is strong genetic correlation between BMI and T2D (rg=0.35; SE=0.04; 
p=4.0E-15; Supplemental Table 4) but no significant correlation between BMI and any of the 
glaucoma-related traits (p≥0.099; Table 3). These findings suggest that if BMI or metabolic 
syndrome plays a role in POAG pathogenesis, they may do so through intermediary effects on 
the glaucomatous process that are not measured in this study.   
 While these results do not support genetic correlations between diabetes and glaucoma, 
there are several non-genetic explanations that can be advanced in support of a positive relation 
between diabetes and glaucoma. For example, it is possible that hyperglycemia leads to the 
accumulation of advanced-glycation end products60 and fibronectin production61 in the trabecular 
meshwork leading to increased IOP in patients with T2D. Several reports indicate that 
experimental diabetes exacerbates IOP-induced optic damage;62-64 however, there is contrary 
evidence that hyperglycemia was neuroprotective in a rodent model of glaucoma.65 Finally there 
is an anecdotal report of a rhesus monkey with spontaneous diabetes, elevated IOP, diabetic 
retinopathy and glaucoma.66  
This study has strengths and weaknesses. Strengths include the use of LD score 
regression, a novel unbiased approach, to assess correlations between many traits where strong 
positive associations are suspected such as IOP and POAG24 and others where there is 
controversy such as T2D and POAG.25,26 Furthermore, our genetic correlation analysis between 
diabetes and glaucoma was extensive as we considered nine diabetes- and eight glaucoma-related 
traits. We included some studies where the genetic architecture for continuous traits were 
ascertained in populations where the prevalence of the respective related diseases (T2D and 
POAG) was minimized.  Such approaches allow for the unbiased detection of novel physiologic 
loci that might be disease-related as well as cross-correlated with another disease.  The absence 
of major genetic correlations between diabetes- and glaucoma-related traits is corroborated by 
pedigree data obtained in two cohorts. In addition, we leveraged the largest available samples of 
genetic data on diabetes- and glaucoma-related traits which were largely adequately powered. 
The cross-correlations within diabetes traits and within glaucoma traits produced expected 
results. For example, we estimated a strong inverse relation between HDL and T2D (rg = -0.40; 
SE = 0.06; p = 4.2E-11; Supplemental Table 4), and a strong positive genetic correlation 
between IOP measured in various ways and POAG, as previously reported.24 Weaknesses 
include the fact that the study was limited to European populations although some, but not all, 
data from Japan are consistent with our findings.26 Second, the absence of a statistically 
significant genetic correlation does not rule out that a minority of genes are truly shared between 
diabetes- and glaucoma-related traits. 
In summary, we found no genetic correlations between comprehensive sets of diabetes- 
and glaucoma-related traits. These findings were supported in analyses from two island-based 
cohorts designed to estimate genetic, environmental and phenotypic correlations in directly 
measured traits that is informed by pedigree data. T2D and related quantitative traits also do not 
share significant genome-wide SNP heritability with POAG or its related traits. It is therefore 
reasonable to consider non-genetic factors, including ones that affect the biomechanical 
properties of the cornea and perhaps even the optic nerve, as mediating the epidemiological 
associations between diabetes and elevated IOP or POAG. These findings have important 
implications for our understanding of POAG. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
   8 
 
Acknowledgements/Disclosures: 
a: Funding/Support: NIH EY015473 (LRP), P30 EY014104 (JLW) and EY022305 (JLW) 
supported this work. AK is supported by a Moorfields Eye Charity Career Development 
Fellowship. SM was supported by an Australian Research Council Fellowship. SM, DAM and 
AWH acknowledge grants 1150144 and 1116360 from the Australian National Health and 
Medical Research Council. 
b: Financial disclosures: The authors have no conflicts of interest to declare with respect to the 
work described. Unrelated to this work, Dr. Pasquale is a consultant for Bausch & Lomb, Verily 
and Eyenovia. Anthony Khawaja is a consultant to Allergan and Novartis, has received travel 
expenses from Thea and has received lecturing fees from Grafton Optical.   
 
c: Other acknowledgements: 
ORCADES Acknowledgements: 
The Orkney Complex Disease Study (ORCADES) was supported by the Chief Scientist Office 
of the Scottish Government (CZB/4/276, CZB/4/710), a Royal Society URF to J.F.W., the MRC 
Human Genetics Unit quinquennial programme “QTL in Health and Disease”, Arthritis Research 
UK and the European Union framework program 6 EUROSPAN project (contract no. LSHG-
CT-2006-018947). DNA extractions were performed at the Wellcome Trust Clinical Research 
Facility in Edinburgh. We would like to acknowledge the invaluable contributions of the 
research nurses in Orkney, the administrative team in Edinburgh and the people of Orkney. 
 
VIKING Acknowledgements: 
The Viking Health Study – Shetland (VIKING) was supported by the MRC Human Genetics 
Unit quinquennial programme grant “QTL in Health and Disease”. DNA extractions and 
genotyping were performed at the Edinburgh Clinical Research Facility, University of 
Edinburgh. We would like to acknowledge the invaluable contributions of the research nurses in 
Shetland, the administrative team in Edinburgh and the people of Shetland. 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
   9 
 
References 
1. Zhao D, Cho J, Kim MH, Friedman DS, Guallar E. Diabetes, fasting glucose, and the risk 
of glaucoma: a meta-analysis. Ophthalmology 2015;122(1):72-8. 
2. Yokomichi H, Kashiwagi K, Kitamura K, et al. Evaluation of the associations between 
changes in intraocular pressure and metabolic syndrome parameters: a retrospective cohort study 
in Japan. BMJ Open 2016;6(3):e010360. 
3. Hashemi H, Khabazkhoob M, Emamian MH, Shariati M, Yekta A, Fotouhi A. 
Distribution of intraocular pressure and its determinants in an Iranian adult population. Int J 
Ophthalmol 2016;9(8):1207-14. 
4. Cohen E, Kramer M, Shochat T, Goldberg E, Krause I. Relationship between serum 
glucose Levels and intraocular pressure, a population-based cross-sectional study. J Glaucoma 
2017;26(7):652-6. 
5. Bekmez S, Kocaturk T. Higher intraocular pressure levels associated with lower 
hysteresis In type 2 diabetes. Open Ophthalmol J 2018;12:29-33. 
6. Luo XY, Tan NYQ, Chee ML, et al. Direct and indirect associations between diabetes 
and intraocular pressure: The Singapore Epidemiology of Eye Diseases Study. Invest 
Ophthalmol Vis Sci 2018;59(5):2205-11. 
7. Goldich Y, Barkana Y, Gerber Y, et al. Effect of diabetes mellitus on biomechanical 
parameters of the cornea. J Cataract Refract Surg 2009;35(4):715-9. 
8. Scheler A, Spoerl E, Boehm AG. Effect of diabetes mellitus on corneal biomechanics and 
measurement of intraocular pressure. Acta Ophthalmol 2012;90(6):e447-51. 
9. Chan MP, Grossi CM, Khawaja AP, et al. Associations with Intraocular Pressure in a 
Large Cohort: Results from the UK Biobank. Ophthalmology 2016;123(4):771-82. 
10. Zhao YX, Chen XW. Diabetes and risk of glaucoma: systematic review and a meta-
analysis of prospective cohort studies. Int J Ophthalmol 2017;10(9):1430-5. 
11. Hou H, Shoji T, Zangwill LM, et al. Progression of primary open-angle glaucoma in 
diabetic and nondiabetic patients. Am J Ophthalmol 2018;189:1-9. 
12. Pimentel LG, Gracitelli CP, da Silva LS, Souza AK, Prata TS. Association between 
glucose levels and intraocular pressure: Pre- and postprandial analysis in diabetic and 
nondiabetic patients. J Ophthalmol 2015;2015:832058. 
13. Wu CJ, Fang WH, Kao TW, et al. Postprandial Glucose as a Risk Factor for Elevated 
Intraocular Pressure. PloS One 2016;11(12):e0168142. 
14. Chun YH, Han K, Park SH, et al. Insulin resistance is associated with intraocular pressure 
elevation in a non-obese Korean population. PLoS One 2015;10(1):e112929. 
15. Fujiwara K, Yasuda M, Ninomiya T, et al. Insulin Resistance Is a Risk Factor for 
Increased Intraocular Pressure: The Hisayama Study. Invest Ophthalmol Vis Sci 
2015;56(13):7983-7. 
16. Klein BE, Klein R, Linton KL. Intraocular pressure in an American community. The 
Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 1992;33(7):2224-8. 
17. Colditz GA, Willett WC, Stampfer MJ, et al. Weight as a risk factor for clinical diabetes 
in women. Am J Epidemiol 1990;132:501-13. 
18. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for 
clinical diabetes mellitus in women. Ann Intern Med 1995;122(7):481-6. 
19. Hu FB, Manson JE, Stampfer MJ, et al. Diet, lifestyle, and the risk of type 2 diabetes 
mellitus in women. N Engl J Med 2001;345(11):790-7. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
   10 
 
20. Chua J, Chee ML, Chin CWL, et al. Inter-relationship between ageing, body mass index, 
diabetes, systemic blood pressure and intraocular pressure in Asians: 6-year longitudinal study. 
Br J Ophthalmol 2018;103(2):196-202. 
21. Bulik-Sullivan B, Finucane HK, Anttila V, et al. An atlas of genetic correlations across 
human diseases and traits. Nat Genet 2015;47(11):1236-41. 
22. Bulik-Sullivan BK, Loh PR, Finucane HK, et al. LD Score regression distinguishes 
confounding from polygenicity in genome-wide association studies. Nat Genet 2015;47(3):291-
5. 
23. Pickrell JK, Berisa T, Liu JZ, Segurel L, Tung JY, Hinds DA. Detection and 
interpretation of shared genetic influences on 42 human traits. Nat Genet 2016;48(7):709-17. 
24. Aschard H, Kang JH, Iglesias AI, et al. Genetic correlations between intraocular pressure, 
blood pressure and primary open-angle glaucoma: a multi-cohort analysis. Eur J Hum Genet 
2017;25(11):1261-7. 
25. Shiga Y, Akiyama M, Nishiguchi KM, et al. Genome-wide association study identifies 
seven novel susceptibility loci for primary open-angle glaucoma. Hum Mol Genet 
2018;27(8):1486-96. 
26. Kanai M, Akiyama M, Takahashi A, et al. Genetic analysis of quantitative traits in the 
Japanese population links cell types to complex human diseases. Nat Genet 2018;50(3):390-400. 
27. Shen L, Walter S, Melles RB, Glymour MM, Jorgenson E. Diabetes pathology and risk 
of primary open-angle glaucoma: Evaluating causal mechanisms by using genetic information. 
Am J Epidemiol 2016;183(2):147-55. 
28. Zheng J, Erzurumluoglu AM, Elsworth BL, et al. LD Hub: a centralized database and 
web interface to perform LD score regression that maximizes the potential of summary level 
GWAS data for SNP heritability and genetic correlation analysis. Bioinformatics 
2017;33(2):272-9. 
29. Scott RA, Lagou V, Welch RP, et al. Large-scale association analyses identify new loci 
influencing glycemic traits and provide insight into the underlying biological pathways. Nat 
Genet 2012;44(9):991-1005. 
30. Saxena R, Hivert MF, Langenberg C, et al. Genetic variation in GIPR influences the 
glucose and insulin responses to an oral glucose challenge. Nat Genet 2010;42(2):142-8. 
31. Soranzo N, Sanna S, Wheeler E, et al. Common variants at 10 genomic loci influence 
hemoglobin A(1)(C) levels via glycemic and nonglycemic pathways. Diabetes 
2010;59(12):3229-39. 
32. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population 
relevance of 95 loci for blood lipids. Nature 2010;466(7307):707-13. 
33. Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new 
insights for obesity biology. Nature 2015;518(7538):197-206. 
34. Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides 
insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 
2012;44(9):981-90. 
35. Hysi PG, Cheng CY, Springelkamp H, et al. Genome-wide analysis of multi-ancestry 
cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucoma. Nat 
Genet 2014;46(10):1126-30. 
36. Springelkamp H, Hohn R, Mishra A, et al. Meta-analysis of genome-wide association 
studies identifies novel loci that influence cupping and the glaucomatous process. Nat Commun 
2014;5:4883. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
   11 
 
37. Bailey JN, Loomis SJ, Kang JH, et al. Genome-wide association analysis identifies 
TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma. Nat 
Genet 2016;48(2):189-94. 
38. Khawaja AP, Cooke Bailey JN, Wareham NJ, et al. Genome-wide analyses identify 68 
new loci associated with intraocular pressure and improve risk prediction for primary open-angle 
glaucoma. Nat Genet 2018;50(6):778-82. 
39. Toh T, Liew SH, MacKinnon JR, et al. Central corneal thickness is highly heritable: the 
twin eye studies. Invest Ophthalmol Vis Sci 2005;46(10):3718-22. 
40. Blanco-Gomez A, Castillo-Lluva S, Del Mar Saez-Freire M, et al. Missing heritability of 
complex diseases: Enlightenment by genetic variants from intermediate phenotypes. BioEssays 
2016;38(7):664-73. 
41. Anttila V, Bulik-Sullivan B, Finucane HK, et al. Analysis of shared heritability in 
common disorders of the brain. Science 2018;360(6395). pii: eaap8757. doi: 
10.1126/science.aap8757 
42. Finucane HK, Bulik-Sullivan B, Gusev A, et al. Partitioning heritability by functional 
annotation using genome-wide association summary statistics. Nat Genet 2015;47(11):1228-35. 
43. McQuillan R, Leutenegger AL, Abdel-Rahman R, et al. Runs of homozygosity in 
European populations. Am J Hum Genet 2008;83(5):359-72. 
44. Clegg FJ. Some factors affecting marital isonymy in three Outer Hebridean parishes. Ann 
Hum Biol 2001;28(4):455-66. 
45. Wiggs JL, Yaspan B, Hauser M, et al. Common variants at 9p21 and 8q22 are associated 
with increased susceptibility to optic nerve degenerationin glaucoma. PLoS Genetics 
2012;8(4):e1002654. 
46. Storr-Paulsen A, Singh A, Jeppesen H, Norregaard JC, Thulesen J. Corneal endothelial 
morphology and central thickness in patients with type II diabetes mellitus. Acta Ophthalmol 
2014;92(2):158-60. 
47. Briggs S, Osuagwu UL, AlHarthi EM. Manifestations of type 2 diabetes in corneal 
endothelial cell density, corneal thickness and intraocular pressure. J Biomed Res 2015;30 doi: 
10.7555/JBR.29.20140075. 
48. Sanchis-Gimeno JA, Alonso L, Rahhal M, Bastir M, Perez-Bermejo M, Belda-Salmeron 
L. Corneal thickness differences between type 2 diabetes and non-diabetes subjects during 
preoperative laser surgery examination. Journal Diabetes Complications 2017;31(1):209-12. 
49. Perez-Rico C, Gutierrez-Ortiz C, Gonzalez-Mesa A, Zandueta AM, Moreno-Salgueiro A, 
Germain F. Effect of diabetes mellitus on Corvis ST measurement process. Acta Ophthalmol 
2015;93(3):e193-8. 
50. Yazgan S, Celik U, Kaldirim H, et al. Evaluation of the relationship between corneal 
biomechanic and HbA1C levels in type 2 diabetes patients. Clin Ophthalmol 2014;8:1549-53. 
51. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and 
primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. 
Arch Ophthalmol 1991;109(8):1090-5. 
52. Tham YC, Cheng CY. Associations between chronic systemic diseases and primary open 
angle glaucoma: an epidemiological perspective. Clin Exp Ophthalmol 2017;45(1):24-32. 
53. Wu SY, Nemesure B, Hennis A, Leske MC. Nine-year changes in intraocular pressure: 
the Barbados Eye Studies. Arch Ophthalmol 2006;124(11):1631-6. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
   12 
 
54. Zhao D, Kim MH, Pastor-Barriuso R, et al. A Longitudinal Study of Association between 
adiposity markers and intraocular pressure: The Kangbuk Samsung Health Study. PLoS One 
2016;11(1):e0146057. 
55. Han X, Yang T, Zhang J, et al. Longitudinal changes in intraocular pressure and 
association with systemic factors and refractive error: Lingtou Eye Cohort Study. BMJ Open 
2018;8(2):e019416. 
56. Pasquale LR, Willett WC, Rosner BA, Kang JH. Anthropometric measures and their 
relation to incident primary open-angle glaucoma. Ophthalmology 2010;117(8):1521-9. 
57. Springelkamp H, Wolfs RC, Ramdas WD, et al. Incidence of glaucomatous visual field 
loss after two decades of follow-up: the Rotterdam Study. Eur J Epidemiol 2017;32(8):691-9. 
58. Newman-Casey PA, Talwar N, Nan B, Musch DC, Stein JD. The relationship between 
components of metabolic syndrome and open-angle glaucoma. Ophthalmology 
2011;118(7):1318-26. 
59. Kim HA, Han K, Lee YA, Choi JA, Park YM. Differential association of metabolic risk 
factors with open angle glaucoma according to obesity in a Korean population. Sci Rep 
2016;6:38283. 
60.  Park CH, Kim JW. Effect of advanced glycation end products on oxidative stress and 
senescence of trabecular meshwork cells. Kor J Ophthalmol 2012; 26(2):123-31. 
61.  Sato T, Roy S. Effect of high glucose on fibronectin expression and cell proliferation in 
trabecular meshwork cells. Invest Ophthalmol Vis Sci 2002;43(1):170–5.  
62.  Kanamori A, Nakamura M, Mukuno H, et al. Diabetes has an additive effect on neural 
apoptosis in rat retina with chronically elevated intraocular pressure. Curr Eye Res 2004; 
28(1):47–54.  
63.  Chysostomous V, vanWijngaarden P, Steinberg GR, Crowston JG. A short term high-fat 
high-sucrose diet in mice impairs optic nerve recovery after injury and this is not reversed by 
exercise. Exp Eye Res 2017; 162:104-9. 
64.  Aleman-Flores R, Mompeo-Corredera B. Glial Cells and Retinal Nerve Fibers 
Morphology in the Optic Nerves of Streptozotocin-induced Hyperglycemic Rats. J Ophthalmic 
Vis Res 2018;13(4):433-8. 
65.  Ebneter A, Chidlow G, Wood JP, Casson RJ. Protection of retinal ganglion cells and 
the optic nerve during short-term hyperglycemia in experimental glaucoma. Arch Ophthalmol 
2011; 129(10);1337-44 
66.  Johnson MA, Lutty GA, McLeod DS, et al. Ocular structure and function in an aged 
monkey with spontaneous diabetes mellitus. Exp Eye Res 2005;80(1):37-42.  
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Table 2: Genetic correlations (standard error) among glaucoma-related traits 
 
 
IOPcc IOPg CCT CH CRF CDR POAG 
 
       
IOP 0.81 
(0.07) 
p=3.8E-34 
1.10 
(0.13) 
p=2.0E-17 
0.58 
(0.07) 
p=1.8E-15 
0.39 
(0.06) 
p=5.0E-10 
0.81 
(0.06) 
p=2.9E-38 
0.08 
(0.07) 
p=0.29 
0.45 
(0.12) 
p=3.0E-04 
IOPcc -- 0.77  
(0.02)  
p~0 
0.07  
(0.05) 
p=0.21 
-0.32  
(0.04) 
p=1.1E-19 
0.16  
(0.04) 
p=7.8E-06 
0.16  
(0.05) 
p=9.3E-04 
0.50 
(0.09) 
p=5.5E-08 
IOPg -- -- 0.48  
(0.07) 
p=3.7E-12 
0.30  
(0.06) 
p=3.2E-07 
0.71  
(0.03)  
p~0 
0.07  
(0.08) 
p=0.39 
0.60 
(0.15) 
p=4.3E-05 
CCT -- -- -- 0.64 
(0.06) 
p=3.0E-24 
0.71  
(0.06) 
p=8.7E-36 
0.08  
(0.06) 
p=0.13 
-0.18 
(0.10) 
p=0.07  
CH -- -- -- -- 0.88  
(0.01)  
p~0 
-0.07  
(0.05) 
p=0.19 
-0.14 
(0.08) 
p=0.07 
CRF -- -- -- -- -- 0.02  
(0.05) 
p=0.66 
0.11 
(0.07) 
0.13 
CDR -- -- -- -- -- -- 0.57 
(0.09) 
p=2.8E-10 
Abbreviations: IOP = intraocular pressure measured with various tonometers in the International 
Glaucoma Genetics Consortium; IOPcc = corneal-compensated intraocular pressure, as 
determined in the UK BioBank study; IOPg = Goldmann-correlated intraocular pressure as 
determined in the UK BioBank study; CCT = central corneal thickness; CH = corneal hysteresis; 
CRF = corneal resistance factor; CDR = cup disc ratio; POAG = primary open angle glaucoma;  
NB: In Tables 2, 3, and 4, we use inverse rank normalized transformed GWAS summary data for 
the right eye for IOPcc, IOPg, CH and CRF.  For CCT we use raw GWAS summary data based 
on the mean from right and left eyes.  P-values corrected for multiple comparisons (<6.9E-04) are 
in bold; p-values < 1E-100 were regarded as ~0.  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Table 3: Genetic correlations (standard error) between body mass index (BMI), blood lipid traits, 
and glaucoma-related traits 
 
BMI LDL HDL TG 
     
IOP 0.07  
(0.04) 
p=0.099 
0.14  
(0.08) 
p=0.059 
0.03  
(0.08)  
p=0.72 
0.01  
(0.05)  
p=0.83 
IOPcc -0.02  
(0.03)  
p=0.60 
0.06  
(0.05)  
p=0.16 
0.06  
(0.05)  
p=0.22 
-0.01  
(0.04)  
p=0.81 
IOPg 0.02  
(0.04)  
p=0.67 
0.07  
(0.05)  
p=0.16 
0.01  
(0.06)  
p=0.84 
0.00  
(0.05)  
p=0.97 
CCT 0.03  
(0.04) 
p=0.37 
0.00  
(0.07) 
p=0.99 
0.07  
(0.06) 
p=0.24 
-0.07  
(0.05) 
p=0.21 
CH 0.03  
(0.03)  
p=0.18 
0.01  
(0.05)  
p=0.84 
-0.02  
(0.04)  
p=0.65 
0.07  
(0.03)  
p=0.05 
CRF 0.03  
(0.02)  
p=0.21 
0.04  
(0.04)  
p=0.38 
0.00  
(0.04)  
p=0.94 
0.06  
(0.03)  
p=0.05 
CDR 0.00  
(0.03) 
p=0.92 
0.02  
(0.05) 
p=0.75 
0.04  
(0.05) 
p=0.42 
-0.02  
(0.04) 
p=0.64 
POAG -0.04  
(0.05) 
p=0.41 
0.04  
(0.09) 
p=0.64 
0.16  
(0.08) 
p=0.06 
-0.06  
(0.07) 
p=0.44 
Abbreviations: IOP = intraocular pressure as measured with various tonometera in the 
International Glaucoma Genetics Consortium; IOPcc = corneal-compensated intraocular pressure 
measured in the UK BioBank study; IOPg = Goldmann correlated intraocular pressure measured 
in the UK BioBank; CCT = central corneal thickness; CH = corneal hysteresis; CRF = corneal 
resistance factor; CDR = cup disc ratio; POAG = primary open angle glaucoma; BMI = body mass 
index; LDL = low density lipoprotein; HDL = high density lipoprotein; TG = triglyceride. 
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Table 4: Genetic correlations (standard error) between diabetes-related traits and glaucoma-
related traits 
 
FBS 2HG     FI HbA1c T2D 
 
     
IOP 0.23  
(0.09) 
p=7.5E-03 
0.17  
(0.16)  
p=0.29 
0.17  
(0.10) 
p=9.1E-02 
0.10  
(0.10)  
p=0.31 
0.08  
(0.07) 
p=0.30 
IOPcc 0.02  
(0.06)  
p=0.71 
-0.01  
(0.09)  
p=0.90 
0.02  
(0.08)  
p=0.83 
-0.01  
(0.07)  
p=0.84 
0.00  
(0.05) 
p=0.98 
IOPg 0.06  
(0.08)  
p=0.47 
0.11  
(0.12)  
p=0.36 
0.02  
(0.09)  
p=0.84 
-0.03  
(0.08)  
p=0.71 
-0.03  
(0.07) 
p=0.62 
CCT 0.04  
(0.07) 
p=0.58 
0.11  
(0.13) 
p=0.38 
-0.04  
(0.08) 
p=0.63 
0.11  
(0.08) 
p=0.13 
0.05  
(0.06) 
p=0.41 
CH 0.03  
(0.06)  
p=0.58 
0.14  
(0.09)  
p=0.12 
0.10  
(0.06)  
p=0.13 
0.03  
(0.06)  
p=0.60 
0.05  
(0.04) 
p=0.24 
CRF 0.05  
(0.06)  
p=0.45 
0.13  
(0.09)  
p=0.14 
0.11  
(0.06)  
p=0.07 
0.04  
(0.05)  
p=0.50 
0.06  
(0.04) 
p=0.16 
CDR 0.06  
(0.06) 
p=0.39 
0.11  
(0.10) 
p=0.28 
-0.02  
(0.09) 
p=0.79 
-0.07  
(0.08) 
p=0.37 
0.07  
(0.07) 
p=0.26 
POAG -0.02  
(0.12) 
p=0.87 
0.04  
(0.16) 
p=0.81 
0.00  
(0.13) 
p=0.99 
-0.31  
(0.14) 
p=0.02 
-0.14  
(0.10) 
p=0.16 
Abbreviations: IOP = intraocular pressure measured with various tonometers in the International 
Glaucoma Genetics Consortium; IOPcc  = corneal-compensated intraocular pressure measured 
in the UK BioBank study; IOPg = Goldmann-correlated intraocular pressure measured in the UK 
BioBank; CCT = central corneal thickness; CH = corneal hysteresis; CRF = corneal resistance 
factor; CDR = cup disc ratio; POAG = primary open angle glaucoma; FBS = fasting blood sugar; 
2HG = 2 hour glucose; FI = fasting insulin; HbA1c = hemoglobin A1c; T2D = type 2 diabetes. 
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Table 1: Summary genome wide association studies used in this analysis 
 
Trait Description of trait 
Sample size 
 
(Study 
PMID) 
 
Population 
characteristics 
Heritability or 
heritability 
rangea 
(Study PMID(s)) 
Heritability 
explained by 
GWAS data 
(SE)b 
FBS Fasting blood sugar 
133,010 
 
(22885924) 
Individuals with 
physician diagnosis 
of  diabetes were 
excluded 
 
0.38-0.52 
 
(10064092, 
10207722, 
11723071) 
 
 
0.03 (0.01) 
 
2HRG 
Glucose level 2 hours 
after oral glucose 
challenge adjusted 
for BMI 
15,234 
 
(20081857) 
 
Individuals with a  
diagnosis of 
diabetes, using 
diabetic medication 
and/or fasting 
glucose ≥7 mM) 
were excluded 
 
 
        0.4 
 
(12898014) 
 
 
 
0.10 (0.03) 
 
FI Fasting insulin 
 
108,557 
 
 (22885924) 
 
 
See 2HRG  
 
0.36 
 
(17956454) 
 
0.03 (0.01)c 
 
HbA1c Serum hemoglobin A 1c levels 
46,368 
 
(20858683) 
See 2HRG 
 
0.47-0.59 
 
(11872688, 
16934002) 
 
 
0.06 (0.01) 
 
LDL Serum LDL 
95,454d 
 
(20686565) 
 
Patients with and 
without dyslipidemia. 
There was no 
systematic attempt to 
exclude subjects with 
diabetes 
 
0.21-0.44 
 
(18165655) 
 
0.12 (0.02) 
HDL Serum HDL 
 
99,900d 
 
(20686565) 
 
See LDL 
0.27-0.48 
 
(18165655) 
 
0.14 (0.02) 
TG Serum triglyceride 
 
96,598d 
 
(20686565) 
 
See LDL 
0.37 
 
(11309690) 
 
 
0.14 (0.02) 
BMI 
 
 
 
Calculated based on 
measured or self-
reported weight and 
height 
 
339,224d 
 
 (25673413) 
Includes patients with 
and without diabetes 
0.47-0.89 
 
(22645519) 
 
0.13 (0.01) 
T2D 
 
Type 2 diabetese 
 
34,840 cases; 
114,981 
controls 
 
(22885922) 
Type 2 diabetes 
0.72 
 
(26678054) 
 
0.05 (0.01) 
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IOP 
 
IOP measured in 
various ways in the 
IGGCf 
 
29,578 
 
(28073927) 
Mostly patients 
without glaucoma. 
0.55 
(20851442) 
 
0.13 (0.02) 
IOPcc 
 
Corneal compensated 
IOP for the right eye 
measured with the 
Reichert tonometer in 
the UKBBg 
 
76,630 
 
(29785010) 
Mostly patients 
without glaucoma NA 
0.15 (0.01)h 
 
IOPg 
 
IOP Goldmann-
correlated for the 
right eye measured 
with the Reichert 
tonometer in the 
UKBBg 
 
76,630 
 
(29785010) 
Mostly patients 
without glaucoma 
measured with the 
Reichert tonometer 
NA 0.19 (0.02)
h 
 
CCT 
Central corneal 
thickness measured 
with a pachymeter as 
the mean of both eyes 
17,803 
 
 (29760442) 
Patients without eye 
disease 
0.68-0.95 
 
(19556215, 
19420341, 
16186354) 
 
 
 
0.34 (0.04) 
CH 
 
Corneal hysteresis of 
the right eye 
measured with 
Reichert tonometer in 
the UKBBg 
 
76,630 
 
(29785010) 
Mostly patients 
without glaucoma NA 0.20 (0.01)
h 
CRF 
 
Corneal resistance 
factor of the right eye 
measured with 
Reichert tonometer in 
the UKBBg 
 
76,630 
 
(29785010) 
Mostly patients 
without glaucoma 
measured with 
Reichert tonometer 
NA 0.25 (0.02)
h 
 
CDR 
Vertical cup-disc 
ratio measured 
various ways in the 
IGGCi 
23,899 
 
(28073927) 
Mostly patients 
without glaucoma 
 
0.48-0.62 
 
(15939473, 
20237253, 
14691154, 
19458335) 
 
0.31 (0.04) 
POAG 
 
Primary optic nerve 
degeneration across 
IOP values in 
Neighborhood 
 
3,853 cases; 
33,480 
controls 
 
 (26752265) 
 
Primary open angle 
glaucoma 
0.70 
 
(28783162) 
0.13 (0.03) 
 
Abbreviations: PMID = PubMed unique identifier; SE = standard error; NA = not available; IOP= 
Intraocular pressure measured in various ways in the International Glaucoma Genetics Consortium (IGGC); 
IOPcc = corneal-compensated IOP; UKBB = United Kingdom BioBank; IOPg = Goldmann-correlated 
IOP; CCT = central corneal thickness; CH = corneal hysteresis; CRF = corneal resistance factor; CDR = 
cup disc ratio; T2D = Type 2 diabetes; POAG = primary open angle glaucoma.    
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a The heritability of a trait is the proportion of trait variance attributable to genetic factors. Estimates for 
heritability values provided here are based on classic twin or family studies with the exception of POAG. 
The latter is based on pedigree analysis of insurance claim data using the generic term ’glaucoma’.    
b Heritability calculated from genome-wide association studies (GWAS) data is the proportion of the 
heritability that is explained by variants that were genotyped. The formula for estimating heritability can be 
found in the appendix.  All heritability estimates are on the observed scale with the exception of POAG and 
T2D. The heritability’s of the latter traits were based on the liability scale assuming a population 
prevalence of 2% and 5% for POAG and T2D, respectively. 
c SE was rounded up to 0.01 
d Sample size for each of these traits in this study. 
e Details regarding how T2D was ascertained are provide in the Appendix. 
f
 For the 1.4% of participants who were on medical therapy for glaucoma, the measured IOP value was 
multiplied by 1.3. Patients with a history of laser trabeculoplasty and incisional glaucoma surgery were 
excluded from analysis. 
g For the 1.5% of participants who were on medical therapy for glaucoma, the measured IOP value was 
multiplied by 1.3. Patients with a history of any laser trabeculoplasty, any incisional glaucoma surgery, any 
eye surgery within the previous 4 weeks, active ocular infection, eye injury, corneal graft surgery or 
refractive laser surgery were excluded. 
h We used inverse rank normalized transformed GWAS summary data for the calculation of heritability for 
these traits. Raw GWAS data yielded materially similar results (data not shown). 
i 1.4% of participants were on medical therapy for glaucoma. Patients with a history of any laser 
trabeculoplasty and any incisional glaucoma surgery were excluded. 
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This study explores genetic correlations between diabetes- and glaucoma-related traits. While 
quantitative glaucoma traits were genetically correlated with primary open-angle glaucoma, none 
of the diabetes-related traits exhibited genetic correlation with any glaucoma-related trait. 
Research should focus on non-genetic factors, such as direct effects of diabetes on the trabecular 
meshwork and the optic nerve, as potential sources of a link between diabetes and glaucoma. 
 
 
